Onco Therapeutics

SJR0.309US

Journal metrics

Annual Clarivate and SCImago indicators.

YearJCRSJR
IFIF quartileRank (percentile)SJRSJR quartileRank (percentile)
20250.309Q344.5%
20220.0%
20210.0%

Impact history

Annual SJR and Impact Factor trend.

SJR

Journal record

eISSN
2694-4650
ISSN
2694-4642
country
US
coverage
2021-2022
Onco Therapeutics | Research Cloud